ACAAI president available to comment on School Access to Emergency Epinephrine Act Dr.

ACAAI president available to comment on School Access to Emergency Epinephrine Act Dr. Stanley Fineman, president of the American University of Allergy, Asthma and Immunology, is available to comment on the institution Usage of Emergency Epinephrine Action, a federal bill launched today that will help make epinephrine obtainable in academic institutions for the instant treatment of anaphylactic reactions to food or additional allergens Click to read more . Dr. Fineman can discuss the importance of immediate usage of epinephrine, the first-range treatment for an allergic crisis or anaphylactic reaction. Delay in treating these reactions can possess serious consequences including death.